Tag Archive for: FDA
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]
NCCS comments on FDA’s draft guidance for in vitro companion diagnostic devices
NCCS filed comments on the Food and Drug Administration's Draft Guidance for Industry and Food and Drug Administration Staff: In…
House passes FDA’s $6.4 billion fee plan for drug reviews
The $6.4 billion accord that Teva Pharmaceutical Industries Inc. (TEVA), Johnson & Johnson (JNJ) (JNJ) and other companies reached…